Performance status-0 - Asymptomatic - Page 17 of 18 Posts on Medivizor
Navigation Menu

Performance status-0 – Asymptomatic Posts on Medivizor

The association between insulin blood levels and risk of death in breast cancer patients

Posted by on Feb 28, 2013 in Breast cancer | 0 comments

In a nutshell The present study evaluated the relationship between high insulin levels in the blood stream and the risk of cancer-related mortality. Its authors report that women with higher-than-normal insulin levels are at higher risk of death due to breast cancer. Some background Breast cancer has been shown to be more common in people who...

Read More

Calcium and magnesium infusions for the treatment of Oxaliplatin-related neuropathy

Calcium and magnesium infusions for the treatment of Oxaliplatin-related neuropathy

Posted by on Feb 26, 2013 in Colorectal cancer | 1 comment

In a nutshell This article evaluates the use of Calcium and magnesium (Ca/Mg) infusions for the prevention of Oxaliplatin-related neurological side effects in patients with colorectal cancer (CRC). The main findings were that Ca/Mg helps preventing neuro-toxic side effects of Oxaliplatin-based chemotherapy regimens. Some background...

Read More

Treating tumors of the appendix to reduce the risk of spread to the abdominal cavity

Posted by on Feb 26, 2013 in Colorectal cancer | 1 comment

In a nutshell The present study classified tumors of the appendix and reviewed treatments that aim to prevent cancer spread to the abdominal cavity. Some background Pseudomyxoma peritonei (PMP) is a rare condition caused by the production of too much mucin (a protein that is secreted in mucus).  PMP affects women more than men and symptoms...

Read More

Personalizing breast cancer treatment based on the genetic “finger-print” of the tumor

Personalizing breast cancer treatment based on the genetic “finger-print” of the tumor

Posted by on Feb 25, 2013 in Breast cancer | 0 comments

This article discusses how tests such as the Oncotype DX or Mammaprint can be used to design individual treatment plans for patients with breast cancer. Patients with stage I and stage II breast cancer are treated similarly. Following surgical removal of a breast tumor, systemic (body-wide) treatment is often used.  This secondary treatment is...

Read More

How soon after surgery for colorectal cancer should chemotherapy be started?

Posted by on Feb 24, 2013 in Colorectal cancer | 0 comments

In a nutshell The present study evaluated the association between time until initiation of adjuvant chemotherapy and survival in colorectal cancer patients. The main findings were that a shorter time until adjuvant chemotherapy improves survival rates in patients with resected colorectal cancer. Some background Colorectal cancers that are within...

Read More

What is the preferred duration of post-operative chemotherapy for stage II and III colorectal cancer?

What is the preferred duration of post-operative chemotherapy for stage II and III colorectal cancer?

Posted by on Feb 24, 2013 in Colorectal cancer | 0 comments

Colorectal cancer (CRC) is one of the main causes of cancer related deaths. Patients diagnosed with CRC are treated with surgery to remove the tumor and affected tissue. If the tumor affects the entire thickness of the colon or rectal wall it is referred to as being stage II; if the local lymph nodes are also affected the cancer is referred to as being a...

Read More

Chemotherapy for cancers of the appendix when surgery is not an option

Chemotherapy for cancers of the appendix when surgery is not an option

Posted by on Feb 24, 2013 in Colorectal cancer | 0 comments

In a nutshell This paper assessed the benefits of giving systemic (whole-body) chemotherapy in cancers of the appendix, when surgery combined with intraperitoneal chemotherapy was not an option. Some background Cancers of the appendix are rare, accounting for about 1% of all colon cancers. However, some of these tumors are aggressive and quickly...

Read More